Jason Raleigh Nunn serves as Executive at HYPERION THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Jason Raleigh Nunn has executed 13 insider transactions totaling $16.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 9, 2025 involved purchasing 63,158 shares valued at $1.2M.
Jason Raleigh Nunn currently holds 1,173,395 shares of HYPERION THERAPEUTICS INC (HPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jason Raleigh Nunn has been a net buyer of HPTX stock. They have purchased $16.2M and sold $0 worth of shares.
Jason Raleigh Nunn's most recent insider trade was on Oct 9, 2025, when they purchased 63,158 shares at $19.00 per share.
Get notified when new Form 4 filings are submitted
| $17.00 |
| Discretionary |
| Sep 16, 2024 | ZBIO | $7.5M | Purchase | 441,176 | $17.00 | Discretionary |
| Sep 16, 2024 | ZBIO | $0 | Conversion | 669,061 | $N/A | Discretionary |
| Sep 16, 2024 | ZBIO | $0 | Conversion | 1,505,388 | $N/A | Discretionary |
| Feb 20, 2020 | DERM | $112.5K | Disposition | 6,000 | $18.75 | Discretionary |
| Jun 12, 2019 | DERM | $0 | Option Exercise | 3,000 | $N/A | Discretionary |
| Jun 13, 2018 | DERM | $0 | Option Exercise | 3,000 | $N/A | Discretionary |
| Dec 9, 2015 | TRVN | $0 | Other | 4,271 | $N/A | Discretionary |
| May 7, 2015 | HPTX | $3.2K | Tender | 70 | $46.00 | Discretionary |
| May 7, 2015 | HPTX | $120.4K | Disposition | 2,617 | $46.00 | Discretionary |
| Jun 5, 2014 | HPTX | $0 | Other | 70 | $N/A | Discretionary |
| May 27, 2014 | HPTX | $0 | Award | 2,617 | $N/A | Discretionary |